Rutgers, The State University of New Jersey
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rutgers, The State University of New Jersey sits in the top decile of US sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count).
Rutgers, The State University of New Jersey: 413 sponsored US clinical trials, 109 recruiting.
Rutgers, The State University of New Jersey sponsors 413 registered US clinical trials on ClinicalTrials.gov, 109 of them currently recruiting, and 196 completed. 35 of these trials are in Phase 3-4 (later-stage) and 104 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 6 trials.
Top-decile sponsor footprint
Rutgers, The State University of New Jersey ranks in the top decile of sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
196 of 267 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
413 total, page 3 of 9
Microbiome Derived Metabolism and Pharmacokinetics
NCT05065671
Exercise and Time of Day in Type 2 Diabetes
NCT05108987
Refinements of Functional Communication Training
NCT04045600
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
NCT04929015
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer
NCT04751747
Virtual Cycling Environments for Persons With Parkinson Disease
NCT04804202
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
NCT03428802
The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes
NCT02447861
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517
Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students
NCT07214428
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
NCT06461273
Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults
NCT06287203
Postprandial Inflammation and Nuts (PIN) in Older Adults
NCT06348771
Adapting BA for Minimally Verbal Autistic Adults
NCT06064422
Skills Video Intervention for Chinese/Chinese Americans
NCT06024083
The Ready and Healthy for Kindergarten Study
NCT05760573
TRE: Microbiome, Metabolic Health and Bone
NCT05548517
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
NCT05411744
Study to Evaluate the Safety of Colchicine
NCT05335148
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
NCT05333874
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
NCT04871516
Bright IDEAS - Young Adults Problem-Solving Skills Training
NCT04585269
Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
NCT04713449
Opioid Analgesic Reduction Study
NCT04452344
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
NCT05220033
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
NCT04253483
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT03677739
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
NCT04294264
Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
NCT03257163
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
NCT02949284
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
NCT02677051
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
NCT02315196
Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial
NCT01260961
Radiation Therapy in Treating Women With Early Stage Breast Cancer
NCT00909909
Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)
NCT07115199
Correcting Disinformation About Menthol Cigarettes and Flavored Cigars
NCT07543081
Produce Prescriptions and Veggie Meter Scores for College Food Security
NCT07511699
Jaw Muscle Pain Post Wisdom Molar Surgery
NCT07094542
FROST-STERN Trial: A Trial of Intraoperative Cryoablation for Post Operative Pain Management After Full Sternotomy
NCT07637370
Developing and Implementing HPV SCREENED
NCT07657104
Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy
NCT07553858
Enhancing Screening Practices for BE
NCT07335445
Comparative Study of Denture Fabrication Techniques
NCT07525011
Evaluating the Feasibility of Prehospital Lung Ultrasound
NCT07549334
Post-Operative Trigeminal Pain After Microvascular Decompression for Trigeminal Neuralgia
NCT07216547
Wildfire Related Air Pollution Exposure and Cognitive Function Pilot Study
NCT07151235
Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy
NCT06979661
Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
NCT06927700
High Impact E-cigarette Advertisement Features
NCT06704295
PFAS Exposure and Immune Response to Vaccination in Adults
NCT06588530
What is open in the Rutgers, The State University of New Jersey pipeline
109 recruiting of 413 indexed (26% open); 196 completed (47%).
Phase mix: 35 late (III/IV) vs 104 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rutgers, The State University of New Jersey: open-pipeline peers nationwide
Peers matched on 413 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Rutgers, The State University of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 413 trials (± recruiting share)
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
Sponsors near 26% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this Rutgers, The State University of New Jersey page
413 registered trials is a research-attention snapshot, not an endorsement of Rutgers, The State University of New Jersey or any single study.
- 109 of Rutgers, The State University of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Rutgers, The State University of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rutgers, The State University of New Jersey pipeline card: 413 registered trials from official public datasets.Report a data error.